Current status with canine lymphoma: Diagnostics and prognosis

April 17, 2018

EJ Ehrhart, DVM, PhD, DACVP (Pathology)a and Kelly Hughes, DVM, DACVPb aEthos Diagnostic Science Division (EthosDx), Ethos Veterinary Health bClinical Immunology, Colorado State University Lymphoma is simply a tumor of lymphocytes. All lymphomas are malignant and have potential to cause direct and indirect, paraneoplastic clinical disease. Lymphoma is one of the most common tumors of

Read More
  • LexaGene Announces Collaboration with Ethos Veterinary Health

    April 4, 2018

    LexaGene Holdings, a biotechnology company that develops instrumentation for pathogen detection, announced today that it has entered into collaboration with Ethos Veterinary Health, a veterinary health company with hospitals across the U.S. that provide advanced medical care for pets.

    Read More
  • Challenges in Diagnosing Lymphoid Neoplasia

    March 9, 2018

    Carolyn Grimes DVM, Dipl ACVP (clinical pathology) The lymphatic system is a beautiful and infinitely complex network of cells, tissues, and organs designed to respond to diverse antigens that may present on almost every pathogen imaginable. The three major types of lymphocytes are T-cells, B-cells, and natural killer (NK) cells. Of these, T-cells and B-cells

    Read More
  • Can Clinical Trials on Dogs and Cats Help People?

    September 16, 2016

    “We can ask much more scientifically rigorous questions that are more likely to intersect with human health,” says Chand Khanna, who founded NIH’s Comparative Oncology Program in 2003 and is now the chief science officer with Ethos Veterinary Health, a new Woburn, Massachusetts-based network of veterinary hospitals that plans to conduct clinical trials. “The mouse

    Read More